Zobrazeno 1 - 10
of 439
pro vyhledávání: '"Doberstein SK"'
Autor:
Dixit N; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Fanton C; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Langowski JL; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Kirksey Y; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Kirk P; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Chang T; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Cetz J; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Dixit V; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Kim G; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Kuo P; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Maiti M; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Tang Y; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., VanderVeen LA; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Zhang P; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Lee M; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Ritz J; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA., Kamihara Y; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA., Ji C; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Rubas W; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Sweeney TD; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Doberstein SK; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA., Zalevsky J; Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA, 94158, USA.
Publikováno v:
Journal of translational autoimmunity [J Transl Autoimmun] 2021 May 06; Vol. 4, pp. 100103. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
Autor:
Gudin J; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, New Jersey.; Pain Management and Wellness Center, Englewood, New Jersey., Rauck R; Carolinas Pain Institute and The Center for Clinical Research, Winston-Salem, North Carolina., Argoff C; Department of Neurology, Albany Medical Center, Albany, New York., Agaiby E; Clinical Investigation Specialists Inc, Kenosha, Wisconsin., Gimbel J; Arizona Research Center, Phoenix, Arizona., Katz N; Tufts University School of Medicine, Boston, Massachusetts.; *Analgesic Solutions, Wayland, Massachusetts., Doberstein SK; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Potts J; Great Lakes Research Group, Inc, Bay City, Michigan., Wild J; Upstate Clinical Research Associates, Williamsville, New York., Lu L; Nektar Therapeutics, San Francisco, California., Siddhanti S; Nektar Therapeutics, San Francisco, California., Hale M; Gold Coast Research, LLC, Plantation, Florida., Markman J; Department of Neurosurgery, Translational Pain Research Program, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Nov 07; Vol. 21 (7), pp. 1347-1356.
Autor:
Henningfield JE; Pinney Associates, Bethesda, Maryland., Gudin J; Englewood Hospital and Medical Center, Englewood, New Jersey., Rauck R; Carolinas Pain Institute and The Center for Clinical Research, Winston-Salem, North Carolina., Gimbel J; Arizona Research Center, Phoenix, Arizona., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Doberstein SK; Nektar Therapeutics, San Francisco, California., Di Fonzo C; Nektar Therapeutics, San Francisco, California., Lu L; Nektar Therapeutics, San Francisco, California., Katz N; Tufts University School of Medicine, Boston, Massachusetts.; Analgesic Solutions, Wayland, Massachusetts, USA., Siddhanti S; Nektar Therapeutics, San Francisco, California., Schnoll S; Pinney Associates, Bethesda, Maryland.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Aug 01; Vol. 21 (8), pp. 1553-1561.
Autor:
Ge X; Nektar Therapeutics, San Francisco, California., Henningfield JE; The Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, Maryland.; Pinney Associates, Bethesda, Maryland., Siddhanti S; Nektar Therapeutics, San Francisco, California., Jobes J; Nektar Therapeutics, San Francisco, California., Lu L; Nektar Therapeutics, San Francisco, California., Xie S; Nektar Therapeutics, San Francisco, California., Ziola M; Nektar Therapeutics, San Francisco, California., Kelsh D; Altasciences Clinical Research, Overland Park, Kansas, USA., Vince B; Altasciences Clinical Research, Overland Park, Kansas, USA., Di Fonzo CJ; Nektar Therapeutics, San Francisco, California., Tagliaferri M; Nektar Therapeutics, San Francisco, California., Zalevsky J; Nektar Therapeutics, San Francisco, California., Doberstein SK; Nektar Therapeutics, San Francisco, California., Hoch U; Nektar Therapeutics, San Francisco, California., Eldon MA; Nektar Therapeutics, San Francisco, California.
Publikováno v:
Pain medicine (Malden, Mass.) [Pain Med] 2020 Feb 01; Vol. 21 (2), pp. e114-e126.
Autor:
Doberstein SK; Nektar Therapeutics, San Francisco, CA, USA.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2019 Dec; Vol. 19 (12), pp. 1223-1228. Date of Electronic Publication: 2019 Oct 31.
Autor:
Lanier RK; Analgesic Solutions, Wayland, MA, USA., Henningfield JE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Pinney Associates, Bethesda, MD, USA., Gudin J; Pain Management Center, Englewood Hospital and Medical Center, Englewood, NJ, USA., Rauck R; Center for Clinical Research, Carolinas Pain Institute, Winston-Salem, NC, USA., Elder H; Analgesic Solutions, Wayland, MA, USA., Erpelding N; Analgesic Solutions, Wayland, MA, USA., Treister R; Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel., Gimbel J; Arizona Research Center, Phoenix, AZ, USA., Tagliaferri M; Nektar Therapeutics, San Francisco, CA, USA., Doberstein SK; Nektar Therapeutics, San Francisco, CA, USA., Di Fonzo CJ; Nektar Therapeutics, San Francisco, CA, USA., Lu L; Nektar Therapeutics, San Francisco, CA, USA., Siddhanti S; Nektar Therapeutics, San Francisco, CA, USA., Katz NP; Analgesic Solutions, Wayland, MA, USA.; Tufts University School of Medicine, Boston, MA, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2019 Sep; Vol. 35 (9), pp. 1513-1522. Date of Electronic Publication: 2019 Apr 01.
Autor:
Markman J; Department of Neurosurgery, Translational Pain Research Program, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States., Gudin J; Pain Management and Palliative Care Center, Englewood Hospital and Medical Center, Englewood, NJ, United States., Rauck R; Carolinas Pain Institute, The Center for Clinical Research, Winston-Salem, NC, United States., Argoff C; Department of Neurology, Albany Medical Center, Albany, NY, United States., Rowbotham M; Sutter Health, CPMC Research Institute, San Francisco, CA, United States., Agaiby E; Clinical Investigation Specialists Inc, Kenosha, WI, United States., Gimbel J; Arizona Research Center, Phoenix, AZ, United States., Katz N; Tufts University School of Medicine, Department of Anesthesia, Boston, MA, United States., Doberstein SK; Nektar Therapeutics, San Francisco, CA, United States., Tagliaferri M; Nektar Therapeutics, San Francisco, CA, United States., Lu L; Nektar Therapeutics, San Francisco, CA, United States., Siddhanti S; Nektar Therapeutics, San Francisco, CA, United States., Hale M; Gold Coast Research, LLC, Plantation, FL, United States.
Publikováno v:
Pain [Pain] 2019 Jun; Vol. 160 (6), pp. 1374-1382.
Autor:
Ferng, Darwin1 (AUTHOR), Sun, Wesley1 (AUTHOR), Shieh, Bih-Hwa1 (AUTHOR) bih-hwa.shieh@vanderbilt.edu
Publikováno v:
PLoS ONE. 6/7/2024, Vol. 19 Issue 6, p1-20. 20p.
Autor:
Lin, Xin1,2,3,4 (AUTHOR), Kang, Kuan1,2,3,4 (AUTHOR), Chen, Pan1 (AUTHOR), Zeng, Zhaoyang1,2,3,4 (AUTHOR), Li, Guiyuan1,2,3,4 (AUTHOR), Xiong, Wei1,2,3,4 (AUTHOR), Yi, Mei5 (AUTHOR) yi_mei@csu.edu.cn, Xiang, Bo1,2,3,4,6 (AUTHOR) xiangbolin@csu.edu.cn
Publikováno v:
Molecular Cancer. 5/18/2024, Vol. 23 Issue 1, p1-50. 50p.
Autor:
Miyazaki T; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Choi IY; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Rubas W; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Anand NK; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Ali C; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Evans J; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Gursahani H; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Hennessy M; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Kim G; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., McWeeney D; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Pfeiffer J; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Quach P; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Gauvin D; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Riley TA; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Riggs JA; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Gogas K; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Zalevsky J; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.)., Doberstein SK; Nektar Therapeutics, San Francisco, California (T.M., I.Y.C., W.R., N.K.A., C.A., J.E., H.G., M.H., G.K., D.M., J.P., P.Q., T.A.R., J.A.R., K.G., J.Z., S.K.D.); and MPI Research, Mattawan, Michigan (D.G.) sdoberstein@nektar.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2017 Oct; Vol. 363 (1), pp. 104-113. Date of Electronic Publication: 2017 Aug 04.